Complementary action of granulocyte macrophage colony-stimulating factor and interleukin-17A induces interleukin-23, receptor activator of nuclear factor-kappa B ligand, and matrix metalloproteinases and drives bone and cartilage pathology in experimental arthritis: rationale for combination therapy in rheumatoid arthritis
Annemarie EM van Nieuwenhuijze, Fons A van de Loo, Birgitte Walgreen, Miranda Bennink, Monique Helsen, Liduine van den Bersselaar, Ian P Wicks, Wim B van den Berg, Marije I Koenders
Arthritis Research & Therapy | BMC | Published : 2015
Awarded by Innovative Medicines Initiative
The authors thank the Central Animal Laboratory animal facility at Radboud University Medical Centre for animal husbandry. This research was supported by the Innovative Medicines Initiative Joint Undertaking funded project BTCure (grant number 115142-2).